Heron Therapeutics, Inc. · NASDAQ:HRTX

Collard Craig A exercised options for 84,810 Heron Therapeutics, Inc. shares (Form 4)

Traded Jul 30 to Jul 31, 2026 · Filed Aug 3, 2026

From Jul 30 to Jul 31, 2026, Collard Craig A (Director, Chief Executive Officer) exercised options for 84,810 Heron Therapeutics, Inc. shares, leaving 856,492 shares. Filed Aug 3, 2026 (Form 4).

Options exercised
84,810 shares
Holding after
856,492 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 30, 2026Common StockOption exercise50,021821,703Direct
Jul 31, 2026Common StockOption exercise34,789856,492Direct

Source

View original at SEC

Related